Q2 2025 · 13F-HR
SECTOR GAMMA ASholdings as filed
Filed 2025-07-31 · accession 0000945621-25-000646
$305.9M
Reported value
38
Positions
2025-06-30
Period end
The Brief · SECTOR GAMMA AS · Q2 2025
AI · grounded in 13F
SECTOR GAMMA AS established a new position in PFE valued at $22.3M. The fund also initiated new stakes in MDT for $19.5M and BMY for $18.8M. Other new additions include BDX, MRK, and GILD.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 717081103 | PFE | PFIZER INC | $22.3M | 7.29% | 920,000 | Common | SOLE |
| G5960L103 | MDT | MEDTRONIC PLC | $19.5M | 6.38% | 224,000 | Common | SOLE |
| 110122108 | BMY | BRISTOL-MYERS SQUIBB CO | $18.8M | 6.14% | 406,000 | Common | SOLE |
| 075887109 | BDX | BECTON DICKINSON & CO | $16.9M | 5.52% | 98,000 | Common | SOLE |
| 58933Y105 | MRK | MERCK & CO INC | $16.0M | 5.23% | 202,000 | Common | SOLE |
| 375558103 | GILD | GILEAD SCIENCES INC | $14.1M | 4.60% | 127,000 | Common | SOLE |
| 45337C102 | INCY | INCYTE CORP | $13.9M | 4.54% | 204,000 | Common | SOLE |
| 031162100 | AMGN | AMGEN INC | $12.3M | 4.02% | 44,000 | Common | SOLE |
| 462222100 | IONS | IONIS PHARMACEUTICALS INC | $11.3M | 3.69% | 285,842 | Common | SOLE |
| 126650100 | CVS | CVS HEALTH CORP | $11.2M | 3.68% | 163,000 | Common | SOLE |
| 14149Y108 | CAH | CARDINAL HEALTH INC | $11.1M | 3.62% | 66,000 | Common | SOLE |
| 883556102 | TMO | THERMO FISHER SCIENTIFIC INC | $10.3M | 3.38% | 25,500 | Common | SOLE |
| 15135B101 | CNC | CENTENE CORP DEL | $8.3M | 2.70% | 152,000 | Common | SOLE |
| 071813109 | BAX | BAXTER INTL INC | $8.1M | 2.65% | 268,007 | Common | SOLE |
| 98956P102 | ZBH | ZIMMER BIOMET HOLDINGS INC | $8.1M | 2.64% | 88,631 | Common | SOLE |
| 116794108 | BRKR | BRUKER CORP | $8.1M | 2.64% | 195,970 | Common | SOLE |
| 036752103 | ELV | ELEVANCE HEALTH INC | $7.3M | 2.39% | 18,779 | Common | SOLE |
| 09061G101 | BMRN | BIOMARIN PHARMACEUTICAL INC | $6.7M | 2.20% | 122,348 | Common | SOLE |
| 09062X103 | BIIB | BIOGEN INC | $6.4M | 2.08% | 50,639 | Common | SOLE |
| 444859102 | HUM | HUMANA INC | $5.7M | 1.88% | 23,500 | Common | SOLE |
| N72482206 | QGEN | QIAGEN NV | $5.6M | 1.84% | 117,000 | Common | SOLE |
| 36266G107 | GEHC | GE HEALTHCARE TECHNOLOGIES I | $5.5M | 1.79% | 74,000 | Common | SOLE |
| 504922105 | LH | LABCORP HOLDINGS INC | $5.1M | 1.67% | 19,484 | Common | SOLE |
| 05352A100 | AVTR | AVANTOR INC | $5.0M | 1.64% | 372,638 | Common | SOLE |
| 69366J200 | PTCT | PTC THERAPEUTICS INC | $4.5M | 1.47% | 92,250 | Common | SOLE |
| 252131107 | DXCM | DEXCOM INC | $4.4M | 1.43% | 50,000 | Common | SOLE |
| 090572207 | BIO | BIO RAD LABS INC | $4.3M | 1.41% | 17,829 | Common | SOLE |
| 28414H103 | ELAN | ELANCO ANIMAL HEALTH INC | $4.2M | 1.36% | 292,073 | Common | SOLE |
| 516544103 | LNTH | LANTHEUS HLDGS INC | $4.1M | 1.35% | 50,301 | Common | SOLE |
| 09075V102 | BNTX | BIONTECH SE | $4.0M | 1.30% | 37,470 | Common | SOLE |
| 875372203 | TNDM | TANDEM DIABETES CARE INC | $3.9M | 1.28% | 210,523 | Common | SOLE |
| 28176E108 | EW | EDWARDS LIFESCIENCES CORP | $3.3M | 1.07% | 42,000 | Common | SOLE |
| 40412C101 | HCA | HCA HEALTHCARE INC | $3.1M | 1.00% | 8,000 | Common | SOLE |
| 88322Q108 | TGTX | TG THERAPEUTICS INC | $3.0M | 0.96% | 82,000 | Common | SOLE |
| 04351P101 | ASNDUSD | ASCENDIS PHARMA A/S | $2.9M | 0.96% | 17,000 | Common | SOLE |
| 83444M101 | SOLV | SOLVENTUM CORP | $2.9M | 0.94% | 38,000 | Common | SOLE |
| 88033G407 | THC | TENET HEALTHCARE CORP | $2.2M | 0.72% | 12,500 | Common | SOLE |
| 03940C100 | ACLXGBX | ARCELLX INC | $1.6M | 0.54% | 25,000 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.